Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Stock Information for Envoy Med Inc Cl A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Envoy Med Inc Cl A

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
Envoy Medical to Participate in the 37th Annual ROTH Conference
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss
Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.